Ann‐Lii Cheng

National Taiwan University of Science and Technology — Taiwan

Medicine · Health Sciences

102h-index76.1kcitations1.3kworks8.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(410), Colorectal Cancer Treatments and Studies(180), Cancer Immunotherapy and Biomarkers(138), Pancreatic and Hepatic Oncology Research(130), Lung Cancer Treatments and Mutations(129)

Publications1.3k total

Expression of Poliovirus Receptor, the Ligand of TIGIT, Associated With Immune-Cold Tumor Microenvironment in Hepatocellular Carcinoma
JCO Precision Oncology·2025
Supplementary Figure 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
2025Open Access
Supplementary Appendix from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
2025Open Access
Supplementary Table 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
2025Open Access
Supplementary Figure 4 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
2025Open Access
Supplementary Figure 2 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
2025Open Access
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study
The Lancet Oncology·2025· 3 cited
Supplementary Methods S1 from Estrogen-DNA Adducts and Breast Cancer Risk in Premenopausal Asian Women
2025Open Access
Supplementary Table S3 from Estrogen-DNA Adducts and Breast Cancer Risk in Premenopausal Asian Women
2025Open Access
Supplementary Table S2 from Estrogen-DNA Adducts and Breast Cancer Risk in Premenopausal Asian Women
2025Open Access
Supplementary Table S1 from Estrogen-DNA Adducts and Breast Cancer Risk in Premenopausal Asian Women
2025Open Access
Aristolochic Acid and Alternative Lengthening of Telomeres Mechanisms Underlie Liver Angiosarcoma Pathogenesis
Liver Cancer·2025Open Access
Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration
Journal of Hepatology·2025· 3 cited
Nanotherapeutics for microenvironment modulation and immune homeostasis in periodontitis treatment
Biomaterials·2025· 1 cited
LBA50 IMbrave152/SKYSCRAPER-14: A phase III study of first-line tiragolumab (tira) + atezolizumab (atezo) + bevacizumab (bev) vs placebo (pbo) + atezo + bev for patients (pts) with untreated locally advanced or metastatic hepatocellular carcinoma (HCC)
Annals of Oncology·2025
1507P Phase I study of ERY974 + atezolizumab (atezo) + bevacizumab (bev) in patients with locally advanced or metastatic hepatocellular carcinoma (HCC)
Annals of Oncology·2025
Re4: Scientific Computing Agent with Rewriting, Resolution, Review and Revision
arXiv (Cornell University)·2025Open Access
[β-sitosterol, an important component in the fruits of <i>Alpinia oxyphylla</i> Miq., prolongs lifespan of <i>Caenorhabditis elegans</i> by suppressing the ferroptosis pathway].
PubMed·2025Open Access
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment
The Lancet·2025· 44 cited
TACOS: Open Tagging and Comparative Scoring for Instruction Fine-Tuning Data Selection
ArXiv.org·2025Open Access
page 1 of 65Next →

Frequent Co-authors

Masatoshi Kudo(23), Shukui Qin(17), Philippe Merle(14), Richard S. Finn(13), В. В. Бредер(11), Masafumi Ikeda(10), Ahmed O. Kaseb(10), Stephen L. Chan(10), Ho Yeong Lim(9), Andrew X. Zhu(8), Peter R. Galle(7), Julien Edeline(7), Pei‐Jer Chen(7), Kwang‐Hyub Han(6), Robin Kate Kelley(6), Chih‐Hung Hsu(6), Thomas Yau(6), Michel Ducreux(5), Daneng Li(5), Wendy Verret(5)